Compare VANI & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | AKA |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.4M | 105.4M |
| IPO Year | 2014 | 2021 |
| Metric | VANI | AKA |
|---|---|---|
| Price | $1.30 | $11.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.50 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 624.4K | 3.3K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,000,000.00 | ★ $600,208,000.00 |
| Revenue This Year | N/A | $6.14 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.44 |
| 52 Week Low | $0.92 | $8.42 |
| 52 Week High | $1.92 | $16.38 |
| Indicator | VANI | AKA |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 63.36 |
| Support Level | $1.17 | $11.26 |
| Resistance Level | $1.34 | $11.44 |
| Average True Range (ATR) | 0.12 | 0.50 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 26.00 | 71.01 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.